Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

60%(3 trials)

Phase Distribution

Ph phase_4

20%

Ph early_phase_1

20%

Ph phase_2

20%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 2Efficacy & side effects

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (20.0%)

Phase 21 (20.0%)

Phase 41 (20.0%)

N/A2 (40.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles

NCT01283464

Clinical Trials (5)

Showing 5 of 5 trials

NCT06105476Not Applicable

Effect of Protein and Retinol on Alcohol-induced FGF21

Completed

NCT05778760Not Applicable

Prospective Study of Topical Adapinoid Versus Topical Retinol

Completed

NCT03112863Early Phase 1

Comparison of the Cosmetic Effects of Bakuchiol and Retinol

Completed

NCT02906566Phase 4

Retinol on Human Skin Aging in East Asian Descent

Completed

NCT01283464Phase 2

Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles

Completed

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5